201 related articles for article (PubMed ID: 21787760)
21. Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.
Liceras-Boillos P; Jimeno D; García-Navas R; Lorenzo-Martín LF; Menacho-Marquez M; Segrelles C; Gómez C; Calzada N; Fuentes-Mateos R; Paramio JM; Bustelo XR; Baltanás FC; Santos E
Mol Cell Biol; 2018 Aug; 38(16):. PubMed ID: 29844066
[TBL] [Abstract][Full Text] [Related]
22. SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.
Baltanás FC; García-Navas R; Santos E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205562
[TBL] [Abstract][Full Text] [Related]
23. Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.
Leshchiner ES; Parkhitko A; Bird GH; Luccarelli J; Bellairs JA; Escudero S; Opoku-Nsiah K; Godes M; Perrimon N; Walensky LD
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1761-6. PubMed ID: 25624485
[TBL] [Abstract][Full Text] [Related]
24. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
[TBL] [Abstract][Full Text] [Related]
25. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.
Liao TJ; Jang H; Fushman D; Nussinov R
Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175
[TBL] [Abstract][Full Text] [Related]
26. SOS GEFs in health and disease.
Baltanás FC; Zarich N; Rojas-Cabañeros JM; Santos E
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188445. PubMed ID: 33035641
[TBL] [Abstract][Full Text] [Related]
27. The catalytic domain of the mouse sos1 gene product activates Ras proteins in vivo and in vitro.
Liu BX; Wei W; Broek D
Oncogene; 1993 Nov; 8(11):3081-4. PubMed ID: 8414509
[TBL] [Abstract][Full Text] [Related]
28. Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling.
Luo G; Wang B; Hou Q; Wu X
J Med Chem; 2023 Apr; 66(7):4324-4341. PubMed ID: 36987571
[TBL] [Abstract][Full Text] [Related]
29. CIIA negatively regulates the Ras-Erk1/2 signaling pathway through inhibiting the Ras-specific GEF activity of SOS1.
Hwang HS; Hwang SG; Yoon KW; Yoon JH; Roh KH; Choi EJ
J Cell Sci; 2014 Apr; 127(Pt 8):1640-6. PubMed ID: 24522193
[TBL] [Abstract][Full Text] [Related]
30. Membrane-dependent signal integration by the Ras activator Son of sevenless.
Gureasko J; Galush WJ; Boykevisch S; Sondermann H; Bar-Sagi D; Groves JT; Kuriyan J
Nat Struct Mol Biol; 2008 May; 15(5):452-61. PubMed ID: 18454158
[TBL] [Abstract][Full Text] [Related]
31. Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.
Rojas JM; Oliva JL; Santos E
Genes Cancer; 2011 Mar; 2(3):298-305. PubMed ID: 21779500
[TBL] [Abstract][Full Text] [Related]
32. Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors.
Tian X; Feig LA
J Biol Chem; 2001 Dec; 276(50):47248-56. PubMed ID: 11560935
[TBL] [Abstract][Full Text] [Related]
33. IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness.
Funato Y; Terabayashi T; Suenaga N; Seiki M; Takenawa T; Miki H
Cancer Res; 2004 Aug; 64(15):5237-44. PubMed ID: 15289329
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
35. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
[TBL] [Abstract][Full Text] [Related]
36. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS.
Hodges TR; Abbott JR; Little AJ; Sarkar D; Salovich JM; Howes JE; Akan DT; Sai J; Arnold AL; Browning C; Burns MC; Sobolik T; Sun Q; Beesetty Y; Coker JA; Scharn D; Stadtmueller H; Rossanese OW; Phan J; Waterson AG; McConnell DB; Fesik SW
J Med Chem; 2018 Oct; 61(19):8875-8894. PubMed ID: 30205005
[TBL] [Abstract][Full Text] [Related]
37. Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.
Cordeddu V; Yin JC; Gunnarsson C; Virtanen C; Drunat S; Lepri F; De Luca A; Rossi C; Ciolfi A; Pugh TJ; Bruselles A; Priest JR; Pennacchio LA; Lu Z; Danesh A; Quevedo R; Hamid A; Martinelli S; Pantaleoni F; Gnazzo M; Daniele P; Lissewski C; Bocchinfuso G; Stella L; Odent S; Philip N; Faivre L; Vlckova M; Seemanova E; Digilio C; Zenker M; Zampino G; Verloes A; Dallapiccola B; Roberts AE; Cavé H; Gelb BD; Neel BG; Tartaglia M
Hum Mutat; 2015 Nov; 36(11):1080-7. PubMed ID: 26173643
[TBL] [Abstract][Full Text] [Related]
38. Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless.
Sondermann H; Nagar B; Bar-Sagi D; Kuriyan J
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16632-7. PubMed ID: 16267129
[TBL] [Abstract][Full Text] [Related]
39. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.
Chen PC; Wakimoto H; Conner D; Araki T; Yuan T; Roberts A; Seidman C; Bronson R; Neel B; Seidman JG; Kucherlapati R
J Clin Invest; 2010 Dec; 120(12):4353-65. PubMed ID: 21041952
[TBL] [Abstract][Full Text] [Related]
40. A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1.
Hart TC; Zhang Y; Gorry MC; Hart PS; Cooper M; Marazita ML; Marks JM; Cortelli JR; Pallos D
Am J Hum Genet; 2002 Apr; 70(4):943-54. PubMed ID: 11868160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
